Lyra Therapeutics, Inc. (19)

Browse by Contract Category

Contracts

Employment Agreement between the Registrant and Jason Cavalier dated as of September 13, 2021 (Filed With SEC on November 9, 2021)
License and Collaboration Agreement dated May 31, 2021, by and between the Registrant and LianBio Inflammatory Limited and LianBio (Filed With SEC on August 9, 2021)
Description of Securities (Filed With SEC on March 9, 2021)
2020 Employee Stock Purchase Plan (Filed With SEC on April 27, 2020)
Transition Agreement between the Registrant and R. Don Elsey dated as of September 12, 2021 (Filed With SEC on November 9, 2021)
Separation Agreement and Release between the Registrant and Laura Edgerly-Pflug, dated July 24, 2020 (Filed With SEC on August 5, 2020)
Form of Indemnification Agreement for directors and officers of the Registrant (Filed With SEC on April 27, 2020)
Offer Letter between the Registrant and Laura Edgerly-Pflug (Filed With SEC on April 27, 2020)
Offer Letter between the Registrant and R. Don Elsey (Filed With SEC on April 27, 2020)
Employment Agreement between the Registrant and Maria Palasis, Ph.D (Filed With SEC on April 27, 2020)
Non-Employee Director Compensation Program (Filed With SEC on April 27, 2020)
2020 Incentive Award Plan and form of agreements thereunder (Filed With SEC on April 27, 2020)
Form of Warrants to Purchase Common Stock, dated various dates, issued by the Registrant to various investors, together with a schedule of warrants and warrantholders (Filed With SEC on April 27, 2020)
Form of Stock Certificate evidencing the shares of common stock (Filed With SEC on April 27, 2020)
Form of Underwriting Agreement (Filed With SEC on April 27, 2020)
Form of Warrants to Purchase Common Stock, dated various dates, issued by the Registrant to various investors, together with a schedule of warrants and warrantholders (Filed With SEC on March 6, 2020)
2016 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on March 6, 2020)
2005 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on March 6, 2020)
Eighth Amended and Restated Investor Rights Agreement, dated as of January 10, 2020 (Filed With SEC on March 6, 2020)